Viewing Study NCT03387020


Ignite Creation Date: 2025-12-25 @ 4:11 AM
Ignite Modification Date: 2026-03-09 @ 2:44 AM
Study NCT ID: NCT03387020
Status: COMPLETED
Last Update Posted: 2021-08-27
First Post: 2017-12-05
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors
Sponsor: Pediatric Brain Tumor Consortium
Organization:

Organization Data

Organization:
Class: NETWORK
Study ID: PBTC-050
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View